UB Paderborn / Katalog / Suche / in CDI

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31

Journal of clinical oncology, 2015-05, Vol.33 (14), p.1574-1583

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

Journal of clinical oncology, 2006-09, Vol.24 (25), p.4196-4201

2006

Link zum Volltext

Verfügbarkeit prüfen

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of clinical oncology, 2022-05, Vol.40 (14), p.1529-1541

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of a clinical trial accrual predictive model

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.6535-6535

2015

Link zum Volltext

Verfügbarkeit prüfen

Developing a predictive model for cancer clinical trial accrual

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.6557-6557

2014

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of a model to predict cancer trial accrual compared to prediction accuracy by investigators at sixteen cancer centers

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.6525-6525

2016

Link zum Volltext

Verfügbarkeit prüfen

CCTG PR21: A randomized phase II study of [ 177 lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5110-TPS5110

2022

Link zum Volltext

Verfügbarkeit prüfen

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1007-1007

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.10513-10513

2018

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS10129-TPS10129

2017

Link zum Volltext

Verfügbarkeit prüfen

Risk prediction model for heart disease among endometrial cancer survivors

Journal of clinical oncology, 2018-03, Vol.36 (7_suppl), p.120-120

2018

Link zum Volltext

Verfügbarkeit prüfen

The NIH Genetic Testing Registry and content tailored for oncologists

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e12543-e12543

2015

Link zum Volltext

Verfügbarkeit prüfen

Landscape scanning of cancer gene panels: A report from the NIH Genetic Testing Registry (GTR)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e13120-e13120

2016

Link zum Volltext

Verfügbarkeit prüfen

Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas

Journal of clinical oncology, 2017-03, Vol.35 (7_suppl), p.23-23

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e14014-e14014

2016

Link zum Volltext

Verfügbarkeit prüfen

The NIH genetic testing registry: Hereditary, pharmacogenetic, and somatic tests for oncology practice

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.11104-11104

2014

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive safety trial of chimeric antibody 14.18 (ch14.18) with GM-CSF, IL-2, and isotretinoin in high-risk neuroblastoma patients following myeloablative therapy: A Children's Oncology Group study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10044-10044

2014

Link zum Volltext

Verfügbarkeit prüfen

Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2003-06, Vol.21 (11), p.2094-2100

2003

Link zum Volltext

Verfügbarkeit prüfen

Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.9534-9534

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1346-1350

2000

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31

Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Validation of a clinical trial accrual predictive model

Developing a predictive model for cancer clinical trial accrual

Accuracy of a model to predict cancer trial accrual compared to prediction accuracy by investigators at sixteen cancer centers

CCTG PR21: A randomized phase II study of [ 177 lu]lu-PSMA-617 verus docetaxel in patients with metastatic castration-resistant prostate cancer and PSMA-positive disease (NCT04663997)

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557)

Impact of exercise on psychological burden in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)

A randomized phase II/III study comparing stereotactic body radiotherapy (SBRT) versus conventional palliative radiotherapy (CRT) for patients with spinal metastases (NCT02512965)

Risk prediction model for heart disease among endometrial cancer survivors

The NIH Genetic Testing Registry and content tailored for oncologists

Landscape scanning of cancer gene panels: A report from the NIH Genetic Testing Registry (GTR)

Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas

Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial

The NIH genetic testing registry: Hereditary, pharmacogenetic, and somatic tests for oncology practice

A comprehensive safety trial of chimeric antibody 14.18 (ch14.18) with GM-CSF, IL-2, and isotretinoin in high-risk neuroblastoma patients following myeloablative therapy: A Children's Oncology Group study

Pilot Trial of the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Gefitinib Plus Carboplatin and Paclitaxel in Patients With Stage IIIB or IV Non–Small-Cell Lung Cancer

Genome-based outcome prediction in MYCN nonamplified high-risk neuroblastoma

Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non–Small-Cell Lung Cancer

Aktive Filter

Suchergebnisse filtern